Your browser doesn't support javascript.
loading
Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia.
Al-Omar, Hussain A; Almodaimegh, Hind S; Omaer, Abubker; Alzubaidi, Lamya M; Al-Harbi, Bandar; Al-Harbi, Ibtisam; Hassan, Mohamed; Akhtar, Omar.
Afiliação
  • Al-Omar HA; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Almodaimegh HS; Health Technology Assessment Unit, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Omaer A; College of Pharmacy, King Saud bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alzubaidi LM; Pharmaceutical Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Al-Harbi B; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Al-Harbi I; Department of Clinical Pharmacy, King Saud Medical City, Riyadh, Saudi Arabia.
  • Hassan M; Therapeutic Deputyship, Ministry of Health, Riyadh, Saudi Arabia.
  • Akhtar O; Department of Pharmacy, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
J Med Econ ; 27(1): 418-429, 2024.
Article em En | MEDLINE | ID: mdl-38420695
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article